Williams MT, Mugno B, Franklin M, et al. Symptom dimensions in obsessive-compulsive disorder: phenomenology and treatment outcomes with exposure and ritual prevention. Psychopathology. 2013;46(6):365-376.
Williams MT, Taylor RJ, Mouzon DM, et al. Discrimination and symptoms of obsessive-compulsive disorder among African Americans. Am J Orthopsychiatry. 2017;87(6):636-645.
Grant JE. Clinical practice: obsessive-compulsive disorder. N Engl J Med. 2014;371(7):646-653.
Pampaloni I, Marriott S, Pessina E, et al. The global assessment of OCD. Compr Psychiatry. 2022;118:152342.
Eisen JL, Sibrava NJ, Boisseau CL, et al. Five-year course of obsessive-compulsive disorder: predictors of remission and relapse. J Clin Psychiatry. 2013;74(3):233-239.
Fineberg NA, Krishnaiah RB, Moberg J, et al. Clinical screening for obsessive-compulsive and related disorders. Isr J Psychiatry Relat Sci. 2008;45(3):151-163.
Veale D, Roberts A. Obsessive-compulsive disorder. BMJ. 2014;348 : g2183.
Hirschtritt ME, Bloch MH, Mathews CA. Obsessive-compulsive disorder: advances in diagnosis and treatment. JAMA. 2017;317(13):1358-1367.
Ruscio AM, Stein DJ, Chiu WT, et al. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53-63.
Ziegler S, Bednasch K, Baldofski S, et al. Long durations from symptom onset to diagnosis and from diagnosis to treatment in obsessive-compulsive disorder: a retrospective self-report study. PLoS One. 2021;16(12):e0261169.
Fenske JN, Petersen K. Obsessive-compulsive disorder: diagnosis and management. Am Fam Physician. 2015;92(10):896-903.
Diagnostic and Statistical Manual of Mental Disorders. 5th ed., text revision. American Psychiatric Association; 2022: 266–267.
Diedrich A, Voderholzer U. Obsessive-compulsive personality disorder: a current review. Curr Psychiatry Rep. 2015;17(2):2.
Koran LM, Hanna GL, Hollander E, et al.; American Psychiatric Association. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007;164(7 suppl):5-53.
Storch EA, Rasmussen SA, Price LH, et al. Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale—Second Edition. Psychol Assess. 2010;22(2):223-232.
National Institute for Health and Care Excellence. Obsessive-compulsive disorder and body dysmorphic disorder. November 29, 2005. Accessed April 23, 2024. https://www.nice.org.uk/guidance/cg31
Stanford Medicine. Obsessive-compulsive and related disorders. Accessed April 23, 2024. https://med.stanford.edu/ocd/about/diagnosis.html
Foa EB, Huppert JD, Leiberg S, et al. The Obsessive-Compulsive Inventory: development and validation of a short version. Psychol Assess. 2002;14(4):485-496.
Storch EA, Kaufman DAS, Bagner D, et al. Florida Obsessive-Compulsive Inventory: development, reliability, and validity [published correction appears in J Clin Psychol. 2007; 63(12): 1265]. J Clin Psychol. 2007;63(9):851-859.
Pellegrini L, Maietti E, Rucci P, et al. Suicide attempts and suicidal ideation in patients with obsessive-compulsive disorder: a systematic review and meta-analysis. J Affect Disord. 2020;276:1001-1021.
Katzman MA, Bleau P, Blier P, et al.; Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014;14(suppl 1):S1.
Jónsson H, Hougaard E, Bennedsen BE. Randomized comparative study of group versus individual cognitive behavioural therapy for obsessive compulsive disorder. Acta Psychiatr Scand. 2011;123(5):387-397.
Lovell K, Cox D, Haddock G, et al. Telephone administered cognitive behaviour therapy for treatment of obsessive compulsive disorder: randomised controlled non-inferiority trial. BMJ. 2006;333(7574):883.
Rees CS, Anderson RA, Kane RT, et al. Online obsessive-compulsive disorder treatment: preliminary results of the “OCD? Not Me!” self-guided internet-based cognitive behavioral therapy program for young people. JMIR Ment Health. 2016;3(3):e29.
Ponniah K, Magiati I, Hollon SD. An update on the efficacy of psychological therapies in the treatment of obsessive-compulsive disorder in adults. J Obsessive Compuls Relat Disord. 2013;2(2):207-218.
Evey KJ, Steinman SA. A systematic review of the use of acceptance and commitment therapy to treat adult obsessive-compulsive disorder. Behav Ther. 2023;54(6):1006-1019.
Skapinakis P, Caldwell DM, Hollingworth W, et al. Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2016;3(8):730-739.
Obsessive compulsive disorder. Evidence update September 2013. A summary of selected new evidence relevant to NICE clinical guideline 31 ‘Obsessive-compulsive disorder: core interventions in the treatment of obsessive-compulsive disorder and body dysmorphic disorder.' September 2013. Accessed April 23, 2024. https://www.ncbi.nlm.nih.gov/books/NBK552052/
Gosmann NP, Costa MA, Jaeger MB, et al. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: a 3-level network meta-analysis. PLoS Med. 2021;18(6):e1003664.
Simpson HB, Huppert JD, Petkova E, et al. Response versus remission in obsessive-compulsive disorder. J Clin Psychiatry. 2006;67(2):269-276.
Foa EB, Simpson HB, Gallagher T, et al. Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation: a randomized clinical trial. JAMA Psychiatry. 2022;79(3):193-200.
Chien WT, Tse M, Chan HYL, et al. Is mindfulness-based intervention an effective treatment for people with obsessive-compulsive disorder? A systematic review and meta-analysis. J Obsessive Compuls Relat Disord. 2022;32:100712.
Bloch MH, Wasylink S, Landeros-Weisenberger A, et al. Effects of ketamine in treatment-refractory obsessive-compulsive disorder. Biol Psychiatry. 2012;72(11):964-970.
Rodriguez CI, Kegeles LS, Levinson A, et al. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology. 2013;38(12):2475-2483.
Pittenger C, Bloch MH, Wasylink S, et al. Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial. J Clin Psychiatry. 2015;76(8):1075-1084.
Emamzadehfard S, Kamaloo A, Paydary K, et al. Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study. Psychiatry Clin Neurosci. 2016;70(8):332-341.
Paydary K, Akamaloo A, Ahmadipour A, et al. N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther. 2016;41(2):214-219.
Ghaleiha A, Entezari N, Modabbernia A, et al. Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study. J Psychiatr Res. 2013;47(2):175-180.
Bruno A, Micò U, Pandolfo G, et al. Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study. J Psychopharmacol. 2012;26(11):1456-1462.
Sayyah M, Boostani H, Pakseresht S, et al. A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder. Psychiatry Res. 2011;189(3):403-406.
Heidari M, Zarei M, Hosseini SMR, et al. Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2014;29(6):344-350.
Kumar KK, Appelboom G, Lamsam L, et al. Comparative effectiveness of neuroablation and deep brain stimulation for treatment-resistant obsessive-compulsive disorder: a meta-analytic study. J Neurol Neurosurg Psychiatry. 2019;90(4):469-473.
National Institute for Health and Care Excellence. Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults. April 28, 2021. Accessed April 23, 2024. https://www.nice.org.uk/guidance/ipg693/resources/deep-brain-stimulation-for-chronic-severe-treatmentresistantobsessivecompulsive-disorder-in-adults-pdf-1899874404226501
Alonso P, Cuadras D, Gabriëls L, et al. Deep brain stimulation for obsessive-compulsive disorder: a meta-analysis of treatment outcome and predictors of response. PLoS One. 2015;10(7):e0133591.
Hudepohl N, MacLean JV, Osborne LM. Perinatal obsessive-compulsive disorder: epidemiology, phenomenology, etiology, and treatment. Curr Psychiatry Rep. 2022;24(4):229-237.
Rowe H, Baker T, Hale TW. Maternal medication, drug use, and breastfeeding. Child Adolesc Psychiatr Clin N Am. 2015;24(1):1-20.
Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2012;51(1):98-113.
Bandelow B, Allgulander C, Baldwin DS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - version 3. Part II: OCD and PTSD. World J Biol Psychiatry. 2023;24(2):118-134.
Piacentini J, Bergman RL, Chang S, et al. Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2011;50(11):1149-1161.
Prato A, Gulisano M, Scerbo M, et al. Diagnostic approach to pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): a narrative review of literature data. Front Pediatr. 2021;9:746639.
Zibordi F, Zorzi G, Carecchio M, et al. CANS: childhood acute neuropsychiatric syndromes. Eur J Paediatr Neurol. 2018;22(2):316-320.
Fenske JN, Schwenk TL. Obsessive-compulsive disorder: diagnosis and management. Am Fam Physician. 2009;80(3):239-245.
Eddy MF, Walbroehl GS. Recognition and treatment of obsessive-compulsive disorder. Am Fam Physician. 1998;57(7):1623-1628.